News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current MYD market cap is 844.61M. The company's latest EPS is USD -1.3942 and P/E is -7.16.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 299.8M | 690.6M | 678.4M | 753.2M | 858.9M |
| Operating Income | -87.8M | -190.5M | -140.6M | -257.4M | -123.5M |
| Net Income | -53.1M | -27.2M | -112M | -263.3M | -127.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.42B | 1.32B | 1.2B | 1.15B | 1.03B |
| Total Liabilities | 537.8M | 352.9M | 312.9M | 363.3M | 326.5M |
| Total Equity | 881M | 967.8M | 885.8M | 783.2M | 701.1M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -73.7M | 18.2M | -106.3M | -110.9M | -8.7M |
| Investing | 28M | 274.4M | -77.5M | 31.9M | -11.9M |
| Financing | -2.1M | -150.6M | -8M | 152.9M | -7.4M |
| Market Cap | 844.61M |
| Price to Earnings Ratio | -7.16 |
| Price to Sales Ratio | 1.06 |
| Price to Cash Ratio | 8.9 |
| Price to Book Ratio | 1.3 |
| Dividend Yield | - |
| Shares Outstanding | 91.31M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.15 (1.61%) |
| Company Name | Myriad Genetics Dl 01 |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.myriad.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
